logo
Share SHARE
FONT-SIZE Plus   Neg

CER Research Says Abbott's Response To Similac Test Results Irresponsible

Hong Kong-based CER Research Friday said Abbott Laboratories Inc.'s (ABT) response to the report released March 22 relating to the safety of the infant formula product Similac Stage 1 was "irresponsible." The report contained results which showed that the Abbott product, purchased in Hong Kong in December, failed two tests by a significant margin.

In its response, which, according to CER Research, was issued in Chinese, Abbott criticized the report for a lack of "scientific-ness, objectivity and fairness." CER Research's rebuttal claims that the results were obtained from "named and recognized laboratories and experts", adding that it has "no independent view" on the product. Further, CER Research said its attempts to contact Abbott were rebuffed.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
At Home Group Inc., the home décor retail store with 115 stores in 29 states is planning to go public. The pricing of initial public offering is expected in a range of $14 to $16 per share. The company in a filing with the SEC said it has got the approval to list the shares on the NYSE under symbol "HOME." McDonald's Corp. has suspended sales of Big Macs in Venezuela as the fast food chain is unable to source buns - one of the key components of a burger. Venezuela is suffering from food shortages recently due to an ongoing economic and political crisis. Telecom giant Verizon Communications Inc. has agreed to acquire the operating business of struggling Internet company Yahoo Inc. for about $4.83 billion in cash, the two companies said Monday. The transaction is expected to close in the first quarter of 2017.
comments powered by Disqus
Follow RTT